News on TAP Pharmaceutical Products Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated TAP Pharmaceutical Products Inc. news from BioPortfolio.com Wed, 10 Feb 2010 15:25:42 GMT en Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042230&HITNO=0&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042230&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042230&HITNO=0&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042230&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039967&HITNO=1&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039967&THISHREF=http://c.moreover.com/click/here.pl%3fz2538502958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039967&HITNO=1&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039967&THISHREF=http://c.moreover.com/click/here.pl%3fz2538502958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products for Distribution Acrosshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039872&HITNO=2&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039872&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039872&HITNO=2&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039872&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039343&HITNO=3&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039343&THISHREF=http://c.moreover.com/click/here.pl%3fz2538043785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039343&HITNO=3&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039343&THISHREF=http://c.moreover.com/click/here.pl%3fz2538043785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038844&HITNO=4&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537798153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038844&HITNO=4&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537798153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038838&HITNO=5&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038838&THISHREF=http://c.moreover.com/click/here.pl%3fz2537796061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038838&HITNO=5&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038838&THISHREF=http://c.moreover.com/click/here.pl%3fz2537796061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: US pharma cos sue Lupin for patent infringementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=6&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=6&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! India: Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039920&HITNO=7&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039920&THISHREF=http://c.moreover.com/click/here.pl%3fz2538473534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039920&HITNO=7&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039920&THISHREF=http://c.moreover.com/click/here.pl%3fz2538473534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039906&HITNO=8&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039906&THISHREF=http://c.moreover.com/click/here.pl%3fz2538462908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039906&HITNO=8&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039906&THISHREF=http://c.moreover.com/click/here.pl%3fz2538462908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=9&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=9&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Integrated Genomics Taps Consulting Firm to Market Microbial Products, Services in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038049&HITNO=10&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038049&THISHREF=http://c.moreover.com/click/here.pl%3fz2537457271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038049&HITNO=10&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038049&THISHREF=http://c.moreover.com/click/here.pl%3fz2537457271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products For Distribution Across Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034087&HITNO=11&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034087&THISHREF=http://c.moreover.com/click/here.pl%3fz2535616533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034087&HITNO=11&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034087&THISHREF=http://c.moreover.com/click/here.pl%3fz2535616533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Transcept Pharmaceuticals Granted First U.S. Patent Coveringhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038038&HITNO=12&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038038&THISHREF=http://c.moreover.com/click/here.pl%3fz2537450604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038038&HITNO=12&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038038&THISHREF=http://c.moreover.com/click/here.pl%3fz2537450604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via MSN Money: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038568&HITNO=13&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038568&THISHREF=http://c.moreover.com/click/here.pl%3fz2537659267%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038568&HITNO=13&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038568&THISHREF=http://c.moreover.com/click/here.pl%3fz2537659267%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038411&HITNO=14&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038411&THISHREF=http://c.moreover.com/click/here.pl%3fz2537597089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038411&HITNO=14&MSIZE=336&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TAP%20Pharmaceutical%20Products%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038411&THISHREF=http://c.moreover.com/click/here.pl%3fz2537597089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAtlanta Business Chronicle: